Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

Recent Press Releases

May 17, 2013 - 4:05 p.m.
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
Printer Friendly Version 
May 15, 2013 - 6:31 p.m.
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
Printer Friendly Version 
May 14, 2013 - 4:06 p.m.
Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
Printer Friendly Version 

Upcoming Events

Friday, May 17, 2013 through Wednesday, May 22, 2013
American Thoracic Society International Conference
Monday, May 20, 2013 9:30 a.m. ET
Gilead Sciences at UBS Global Healthcare Conference
Wednesday, May 29, 2013 through Friday, May 31, 2013
38th Annual Deutsche Bank Healthcare Conference
Friday, May 31, 2013 through Tuesday, June 4, 2013
American Society of Clinical Oncology Annual 2013 Meeting
Tuesday, June 11, 2013 through Thursday, June 13, 2013
34th Annual Goldman Sachs Healthcare Conference
Tuesday, June 18, 2013 through Wednesday, June 19, 2013
Wells Fargo Securities Research & Economics 2013 Healthcare Conference

Most Viewed Links

Updated 05/18/13
1.SEC Filings
2.Stock Information
3.Stock Quote
4.Annual Reports
5.Gilead Science at Bank of America Merrill Lynch 2013 Health Care Conference
* Data collected 05/10/13 - 05/17/13

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$56.30
 Stock is Up 1.34 (2.44%)
Data as of 05/17/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay
Gilead Science at Bank of America Merrill Lynch 2013 Health Care Conference

May 15, 2013 9:20 a.m. PT
Play
First Quarter 2013 Gilead Sciences Earnings Conference Call

May 02, 2013 4:30 p.m. ET
Play
  • 2012 Annual Report  
  • 2012 Form 10-K  
  • Financial Tear Sheet  
Get help downloading or viewing the above file types